Impact of BNT162b2 primary vaccination and homologous booster on anti-SARS-CoV-2 IgA antibodies in baseline seronegative healthcare workers.

Gian Luca SalvagnoBrandon M HenryLaura PighiSimone De NittoGiuseppe Lippi

Published in: Advances in laboratory medicine (2022)

These results support the suggestion that vaccine boosters may be advisable after 3 months from primary vaccination to restore IgA to protective levels, especially in those at higher risk of SARS-CoV-2 infection and complications.

Keyphrases

sars cov
respiratory syndrome coronavirus
dna damage
risk factors
dna repair